We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Ananda Developments Plc | AQSE:ANA | Aquis Stock Exchange | Ordinary Share | GB00BDQPXQ60 |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 0.475 | 0.40 | 0.60 | 0.50 | 0.46 | 0.475 | 903,252 | 15:29:42 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
0 | 0 | N/A | 0 |
TIDMANA
RNS Number : 8031H
Ananda Developments PLC
31 July 2023
31 July 2023
ANANDA DEVELOPMENTS PLC
("Ananda" or the "Company")
Completion of Audit, Publication of Annual Report and Accounts and Notice of Annual General Meeting
Further to the announcement of its 2022/23 unaudited preliminary results on 13 July 2023, Ananda announces that the audit for the year ended 31 January 2023 has now been completed. Adjustments have been made to the previously notified Consolidated Statement of Cashflows and Balance Sheet, which are reflective of adjustments made a part of a review of the acquisition of DJT Group Limited, revised tables are set out below.
The Company's Annual Report and Accounts for the year ended 31 January 2023, together with a Notice of Annual General Meeting, has been published on the Company's website. The notice of Annual General Meeting have also today been posted to, or emailed to, shareholders as appropriate in accordance with the provision in the Company's articles of association on electronic communications.
The Annual General Meeting is due to be held at the offices of Shakespeare Martineau Llp, 6(th) Floor, 60 Gracechurch Street, London, EC3V 0HR at 2.00pm on 24(th) August 2023.
Statement of Financial Position
GROUP 31 Jan 31 Jan 2023 2022 Note GBP GBP Non-Current assets Tangible Assets 10 1,762,468 - Intangible Assets 12 4,470,376 - Investments in subsidiaries - 2,252,192 ------------ ------------ Total non-current assets 6,232,844 2,252,192 Current assets Cash and cash equivalents 18,837 - Assets under construction 47,080 - Trade and other receivables 14 210,144 110,938 Total current assets 276,061 110,938 ------------ ------------ Current liabilities Trade and other payables 15 1,586,484 1,487,254 Convertible loan notes 16 2,924,812 - Total current liabilities 4,511,296 2,075,114 ------------ ------------ Non-current liabilities Convertible loan notes 16 - 587,860 Deferred Tax Liability 793,000 - Total assets less liabilities 1,204,609 288,016 ============ ============ Capital and reserves Share capital 18 2,341,110 1,597,031 Share premium 3,468,944 876,347 Share options reserve 32,499 18,788 Retained earnings (4,637,944) (2,204,150) Total equity and liabilities 1,204,609 288,016 ============ ============
Statement of Cash Flows
GROUP 31 Jan 2023 Note GBP Cash flows from operating activities Loss for the year (1,139,640) Adjustments for: Depreciation 172,284 Share based payment expense 13,711 Net finance expense 247,983 Write-off of assets under construction 39,878 Write-off of stocks 7,393 Increase in trade and other receivables (143,568) Increase in trade and other payables 344,604 Net cash outflow from operating activities 19 (457,354) -------------- Investing activities Cash from acquisition 29,563 Additional investments prior to DJT acquisition (1,476,598) -------------- Net cash outflow from investing activities (1,446,944) -------------- Financing activities Proceeds from loans and borrowings 1,888,845 Repayment of loans and borrowings (40,000) Proceeds from issue of ordinary shares 74,290 Net cash inflow from financing activities 1,923,135 -------------- Net decrease in cash and cash equivalents 18,837 Cash and cash equivalents at beginning - of period Cash and cash equivalents at end of year 18,837 ==============
-Ends-
The Directors of the Company accept responsibility for the contents of this announcement.
ANANDA DEVELOPMENTS PLC +44 (0)7463 686 497 ir@anandadevelopments.com Chief Executive Officer Melissa Sturgess Finance Director Jeremy Sturgess-Smith SP ANGEL CORPORATE FINANCE LLP +44 (0)20 3470 0470 Corporate Finance Richard Morrison Harry Davies-Ball Corporate Broking Abigail Wayne Rob Rees
About Ananda Developments
Ananda is an AQSE-listed company whose ambition is to be a leading provider of cannabinoid-based medicines for the treatment of complex, chronic inflammatory pain conditions.
For more information, please visit: https://anandadevelopments.com/
Market Abuse Regulation (MAR) Disclosure
The information contained within this announcement is deemed by the Company to constitute inside information. Upon the publication of this announcement via a Regulatory Information Service, this inside information is now considered to be in the public do main.
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
END
NEXFLFVRDAILVIV
(END) Dow Jones Newswires
July 31, 2023 12:44 ET (16:44 GMT)
1 Year Ananda Developments Chart |
1 Month Ananda Developments Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions